Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,940,510 papers from all fields of science
Search
Sign In
Create Free Account
tafluprost
Known as:
1-methylethyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate
, Isopropyl (5z)-7-((1R,2R,3R,5S)-2-((1E)-3,3-Difluoro-4-Phenoxybut-1-Enyl)-3,5-Dihydroxycyclopentyl)Hept-5-Enoate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Narrower (2)
AFP-168
Zioptan
Prostaglandins
analogs & derivatives
Broader (1)
Prostaglandins F
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
[Tafluprost--a novel prostaglandin F2alpha analogue].
S. Petrov
Vestnik oftal mologii
2014
Corpus ID: 31305593
The review provides a brief history of the evolution of ophthalmic containers: from glass vials to plastic bottles with…
Expand
2014
2014
Improved synthesis of tafluprost
Chen Gang
,
Zeng Lingguo
,
Xie Jian-yong
,
Li Qin-geng
2014
Corpus ID: 102854172
The target compound was synthesized through Swern oxidation,Hormer-Wadsworth-Emmons reaction,fluorination,hydrolysis,reduction…
Expand
2013
2013
A synthetic method of tafluprost
杨波
,
李延华
2013
Corpus ID: 103203081
The present invention relates to a process for the synthesis of tafluprost, compounds and intermediates involved in the process…
Expand
Review
2013
Review
2013
Tafluprost: A Systematic Review of Pharmacology and Therapeutic Potential in the Management of Glaucoma and Ocular Hypertension
R. Nandha
,
Harpal Singh
2013
Corpus ID: 72373430
Glaucoma is the second most common cause of blindness worldwide. Treatment of glaucoma mainly aims at improving the visual loss…
Expand
2012
2012
Фармакоэкономические аспекты терапии никотиновой зависимости у пациентов со стенокардией, нуждающихся в кардиохирургических вмешательствах
Рудакова Алла Всеволодовна
,
Бережнова Мария Сергеевна
2012
Corpus ID: 74920095
Smoking is a major risk factor in patients with angina pectoris. Interventions that facilitate the rejection of it are an…
Expand
2012
2012
[Efficacy and tolerability of preservative-free tafluprost 0.0015 % in the treatment of glaucoma and ocular hypertension].
M. Karhanová
,
P. Mlčák
,
Z. Fryšák
,
K. Marešová
Czech and Slovak Ophthalmology
2012
Corpus ID: 261369022
AIM The aim of the study was to evaluate the efficacy, safety and local tolerability of preservative-free tafluprost 0.0015…
Expand
2010
2010
Pharmacoeconomic Analysis of Tafluprost compared with Latanoprost on the Treatment of Primary open Angle Glaucoma or Ocular Hypertension in Korea
Sukhyun Kang
,
H. Song
,
J. Heo
,
E. Lee
2010
Corpus ID: 79555304
The main objective of this study is to evaluate the cost-effectiveness of tafluprost compared with latanoprost in primry open…
Expand
Review
2008
Review
2008
Overview of the profile of tafluprost
H. Uusitalo
2008
Corpus ID: 71901523
Purpose Tafluprost (Taflotan®) is a new potent PGF2_ analogue for the treatment of glaucoma. Tafluprost is the first…
Expand
2007
2007
Pharmacokinetics of preserved and preservative-free formulations of tafluprost are comparable in healthy volunteers
H. Uusitalo
,
K. Kaarniranta
,
A. Ropo
2007
Corpus ID: 72046257
Purpose: Prostanoid F2α (PF2α) analogues effectively lower intraocular pressure and are used as first-line treatment of glaucoma…
Expand
2007
2007
Adjunctive use of tafluprost with timolol provides additive effects for reduction in intraocular pressure in patients with glaucoma
E. Egorov
,
A. Ropo
2007
Corpus ID: 72339244
Purpose: Beta-blockers and prostanoid F2α (PF2α) analogues reduce intraocular pressure (IOP) by complementary mechanisms. A…
Expand